COPD

October 17, 2011

Patients with rheumatoid arthritis have a high risk of concomitant chronic obstructive pulmonary disease, according to data from two studies.

September 28, 2011

Daily azithromycin prevented acute exacerbations of chronic obstructive pulmonary disease when it was added to usual treatment in a 1-year study, thus improving patients’ quality of life.

August 02, 2011
COPD is the third leading cause of death in the United States and the fourth leading cause of death worldwide.
July 04, 2011

New research shows that indacaterol is effective and well tolerated for patients with moderate to severe chronic obstructive pulmonary disease (COPD).

April 20, 2011

The majority of a Food and Drug Administration advisory panel recommended that the inhaled bronchodilator indacaterol should be approved for patients with chronic obstructive pulmonary disease, to be taken at a dose of 75 mcg once daily.

October 27, 2010

November Is COPD Awareness Month

October 22, 2010

Each year, millions of travelers fly on commercial airlines in the United States and around the globe. As air travel has become more affordable, it has also become more accessible for people with serious medical conditions—including lung disease.

September 22, 2010

Each year, millions of travelers fly on commercial airlines in the United States and around the globe. As air travel has become more affordable, it has also become more accessible for people with serious medical conditions—including lung disease.

August 10, 2010

Low-dose oral corticosteroids are as effective as high-dose intravenous corticosteroids in the initial treatment of acute exacerbations of COPD, according to findings from a retrospective cohort study of nearly 80,000 COPD hospitalizations.

June 14, 2010

Volume 24, Lesson 12

Take advantage of this unique educational program offered by the ACCP. Each month, a distinguished editorial board of expert clinicians will provide two lessons, featuring timely, concise, diagnostic information on current pulmonary, critical care, and sleep medicine issues. Earn up to 24.0 AMA PRA Category 1 credit(s)™. One (1) credit will be awarded for each completed lesson.

May 14, 2010

Volume 24, Lesson 10

Take advantage of this unique educational program offered by the ACCP. Each month, a distinguished editorial board of expert clinicians will provide two lessons, featuring timely, concise, diagnostic information on current pulmonary, critical care, and sleep medicine issues. Earn up to 24.0 AMA PRA Category 1 credit(s)™. One (1) credit will be awarded for each completed lesson.

April 14, 2010

Sometimes it's good just to point out good stuff that you might be interested in reading. Here's a list of links to some recent articles from various sources. Enjoy! For more stuff like this, join me on Twitter.

March 08, 2010
Learn more about CHEST 2010
February 23, 2010

Have you been waiting for the ACCP-SEEK app to include pulmonary and critical care questions? Well, the new version is now available in iTunes and contains 400 more questions!

February 01, 2010
This is a follow-up to previous Early Communications issued in 2008 by the US Food and Drug Administration (FDA) describing a potential increase in the risk of stroke, heart attack, or death from a cardiovascular cause related to the use of tiotropium, which is marketed as Spiriva HandiHaler.
January 01, 2010
2010: The Year of the Lung (YOL) is a global initiative instituted by the Forum of International Respiratory Societies (FIRS), a collaboration of the world’s leading professional respiratory organizations, including the American College of Chest Physicians.
December 22, 2009